SOURCE: GS MEDIA // Beststocksdaily.com

Beststocksdaily.com Issues Investment Alert On (OTC:CBAI), (OTC:ADXS), (OTC:ATTD), (OTC:ACTC), (OTC:SVEN)

Beststocksdaily.com Is announcing Investment Highlights on Cord Blood America Inc (OTC:CBAI), Advaxis Inc (OTC:ADXS), Attitude Drinks Inc (NDA) (OTC:ATTD), Advanced Cell Technology Inc (OTC:ACTC)

LOS ANGELES, CA - January 15, 2013 - - Cord Blood America Inc (OTC: CBAI) soared 2.78% to $0.0037 on a traded volume of 6.83 million shares. So far this year, the stock is down over 26%. The 52-week range for the stock is $0.0 and $0.05. 

Will CBAI Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=CBAI

Advaxis Inc (OTC: ADXS) augmented 9.56% to $0.055 on a traded volume of 11.09 million shares. Recently, the Company appointed Daniel J. O’Connor to the position of Senior Vice President, Chief Legal and Business Development Officer. In the last one year, the stock is down over 67%. The 52-week range for the stock is $0.03 and $0.18. Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. 

How Should Investors Trade ADXS After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=ADXS

Attitude Drinks Inc (NDA) (OTC: ATTD) slipped 33.33% to $0.0002 on a traded volume of 28.48 million shares. Recently, SmallCapVoice.com Inc. announced that a new audio interview with American Attitude Drinks is now available. The interview was with Roy Warren, CEO of Attitude Drinks. Attitude Drinks, Inc is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. 

Get Free Special Trend Analysis On ATTD Here http://beststocksdaily.com/p2/index.php?company=ATTD

Advanced Cell Technology Inc (OTC: ACTC) surged up 7.14% to $0.087 on a traded volume of 10.65 million shares. The Company announced that investigators for the Company's Phase I/II clinical trials for Stargardt's macular dystrophy and dry age-related macular degeneration have observed evidence of engraftment of the transplanted human embryonic stem cell derived retinal pigment epithelial cells and visual acuity gain in patients treated over the 18 months since the trials were first initiated. 

Get Free Special Trend Analysis On ACTC Here http://beststocksdaily.com/p2/index.php?company=ACTC

Superior Venture Corp (OTC: SVEN) went down 4.24% to $0.0113 on a traded volume of 2.22 million shares. The stock opened at $0.01. The 52-week range for the stock is $0.01 and $0.35. The 50-Day Moving Average and 200-Day Moving Average prices is $0.02 and $0.02 respectively. The organization is a development stage company, intends to produce and sell wine varietals. The Company was founded in April 2010 and is based in Centennial, Colorado.

 Get Free Special Trend Analysis On SVEN Here http://beststocksdaily.com/p2/index.php?company=SVEN

About Beststocksdaily

Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.

Disclaimer:

The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.

 

Contact:

Brain Burr

Beststocksdaily

1419 Westwood Blvd Los Angeles, CA

90024-4911

staff@beststocksdaily.com

www.beststocksdaily.com 

 

 

SOURCE Beststocksdaily.com